Back

Radiosurgery for ventricular tachycardia (RAVENTA): Final results of a German multicenter multiplatform feasibility trial

31 March 2025 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Management of complex ventricular arrhythmias Radiotherapy EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Oliver Blanck

University Medical Center of Schleswig-Holstein, Kiel (Germany)

6 More presentations in this session

Presentation thumbnail
STAR SHAPe: validation of predictive features for redo catheter ablation using an explainable AI algorithm for stereotactic arrhythmia radioablation
Mr A. Mircea (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Electrotomographic mapping: clinical translation for multipolar principal component referenced unipolar electrograms
Doctor N. Denham (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Survival, therapeutics and clinical prognosis after bidirectional ventricular tachycardia
Doctor R. Vazirani Ballesteros (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of stereotactic arrhythmia radioablation for ventricular arrhythmias using a novel multimodal fusion workflow for target delineation
Doctor M. Dezecot (Rennes, FR)
Abstract Slides Video
Presentation thumbnail
Evaluation of Mid-position based treatment planning for stereotactic radioablation of ventricular tachycardia
Professor R. Martins (Rennes, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Management of complex ventricular arrhythmias

The Event

Event poster

EHRA 2025

31 March 2025 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Increase in ventricular tachycardia burden during the blanking period after stereotactic arrhythmia radioablation - preliminary results from the CREVET study
31 March 2025
thumbnail
Congress Session
Late-breaking science on valve disease and hypertrophic cardiomyopathy
28 August 2023
thumbnail
Congress Presentation
Post-infarct VT substrate ablation based on evoked delayed potential elimination as well-defined target: results from a prospective multicenter study.
26 August 2022
thumbnail
Congress Presentation
Standardization of stereotactic arrhythmia radioablation (STAR): a systematic meta-review on reporting quality and adherence to EHRA and ICRU recommendations on behalf of the STOPSTORM.eu consortium
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources